Rising home prices boosted the markets during the midday with the Dow climbing 89 points to 14,537. Nasdaq gained 11 points to 3246.
On the upside
A Seeking Alpha contributor expects Opexa Therapeutics (Nasdaq: OPXA) to climb in both the short term as well as the long term.
Just Energy (NYSE: JE) expects to report earnings of $1.57 per share in fiscal 2014.
On the downside
Glancy Binkow & Goldberg filed a class action lawsuit against Affymax (Nasdaq: AFFY) for issuing false and misleading statements.
A Seeking Alpha contributor raised concerns about Amarin's (Nasdaq: AMRN) sales strategy for its recently approved fish oil product Vascepa.
Several law firms are seeking lead plaintiffs for securities fraud class action lawsuits against Star Scientific (Nasdaq: STSI).
In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 3 on the NYSE while decliners barely edged out advancers by nearly 10 to 9 on Nasdaq. The broader S&P 500 index climbed 8 points to 1560.